Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

FLT3 anticorps (AA 589-593)

FLT3 Reactivité: Humain IF Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN362818
  • Antigène Voir toutes FLT3 Anticorps
    FLT3 (Fms-Related tyrosine Kinase 3 (FLT3))
    Épitope
    • 20
    • 18
    • 18
    • 15
    • 12
    • 12
    • 9
    • 8
    • 7
    • 7
    • 7
    • 5
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 589-593
    Reactivité
    • 160
    • 57
    • 7
    • 4
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 159
    • 17
    • 6
    • 1
    Lapin
    Clonalité
    • 160
    • 23
    Polyclonal
    Conjugué
    • 69
    • 15
    • 11
    • 9
    • 8
    • 7
    • 7
    • 7
    • 7
    • 7
    • 7
    • 6
    • 4
    • 4
    • 4
    • 4
    • 4
    • 2
    • 1
    Cet anticorp FLT3 est non-conjugé
    Application
    • 127
    • 69
    • 54
    • 54
    • 37
    • 26
    • 20
    • 14
    • 9
    • 8
    • 5
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    Immunofluorescence (IF)
    Specificité
    The antibody detects endogenous level of total FLT3 protein.
    Purification
    The antibody was affinity-purified from rabbit antiserum by affinity-chromatography usingepitope-specific immunogen.
    Immunogène
    Peptide sequence around AA 589-593 (Y-F-Y-V-D) derived from Human FLT3. Antibodies were produced by immunizing rabbits with synthetic peptide and KLH conjugates.
    Isotype
    IgG
    Top Product
    Discover our top product FLT3 Anticorps primaire
  • Indications d'application
    Western blotting: 1:500-1:1000
    Immunofluorescence: 1:100-1:200
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    1 mg/mL
    Buffer
    Phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C/-20 °C
    Stockage commentaire
    Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
  • Ninagawa, Murakami, Isobe, Tanaka, Nakagawa, Torihashi: "Mesenchymal stem cells originating from ES cells show high telomerase activity and therapeutic benefits." dans: Differentiation; research in biological diversity, Vol. 82, Issue 3, pp. 153-64, (2011) (PubMed).

    Meads, Nouwen: "Does emotional disclosure have any effects? A systematic review of the literature with meta-analyses." dans: International journal of technology assessment in health care, Vol. 21, Issue 2, pp. 153-64, (2005) (PubMed).

  • Antigène
    FLT3 (Fms-Related tyrosine Kinase 3 (FLT3))
    Autre désignation
    FLT3 (FLT3 Produits)
    Synonymes
    anticorps FLT3, anticorps B230315G04, anticorps CD135, anticorps Flk-2, anticorps Flk2, anticorps Flt-3, anticorps Ly72, anticorps wmfl, anticorps FLK-2, anticorps FLK2, anticorps STK1, anticorps fms related tyrosine kinase 3, anticorps FMS-like tyrosine kinase 3, anticorps fms-related tyrosine kinase 3, anticorps FLT3, anticorps Flt3
    Sujet
    FLT3 encodes a class III receptor tyrosine kinase that regulates hematopoiesis. The receptor consists of an extracellular domain composed of five immunoglobulin-like domains, one transmembrane region, and a cytoplasmic kinase domain split into two parts by a kinase-insert domain. The receptor is activated by binding of the fms-related tyrosine kinase 3 ligand to the extracellular domain, which induces homodimer formation in the plasma membrane leading to autophosphorylation of the receptor. The activated receptor kinase subsequently phosphorylates and activates multiple cytoplasmic effector molecules in pathways involved in apoptosis, proliferation, and differentiation of hematopoietic cells in bone marrow. Mutations that result in the constitutive activation of this receptor result in acute myeloid leukemia and acute lymphoblastic leukemia.
    Poids moléculaire
    160 kDa
    NCBI Accession
    NP_004110
    UniProt
    P36888
    Pathways
    Signalisation RTK
Vous êtes ici:
Support technique